Home › Chronic Lymphocytic Leukemia › Minnesota

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Minnesota

30 pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa Minnesota.

Mga Lungsod sa Minnesota

Opisyal na teksto ng pag-aaral (English)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Mercy Hospital, Coon Rapids
Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
at 10 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04269902

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

University of Minnesota, Minneapolis

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06846671

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Avera Cancer Institute - Marshall ( Site 5462), Marshall

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT05947851

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Mayo Clinic Rochester, Rochester

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05091424

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Minnesota Oncology Hematology, P.A., Coon Rapids

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07218341

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Riverwood Healthcare Center, Aitkin
Mayo Clinic Health System in Albert Lea, Albert Lea
Essentia Health - Baxter Clinic, Baxter
at 49 pa

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Sanford Joe Lueken Cancer Center, Bemidji
Essentia Health Saint Joseph's Medical Center, Brainerd
Minnesota Oncology - Burnsville, Burnsville
at 13 pa

Nagre-recruitPhase 3

Edad 65 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07321652

Family Study of Lymphoproliferative Disorders

Mayo Clinic, Rochester

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT00626496

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Mayo Clinic in Rochester, Rochester

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT03516617

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Mayo Clinic, Clinical Trials Referral Office, Rochester

Nagre-recruitPhase 1/2

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06533579

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Mayo Clinic Rochester, Rochester

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT06943872

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

Mayo Clinic Health System in Albert Lea, Albert Lea
Sanford Joe Lueken Cancer Center, Bemidji
Essentia Health Saint Joseph's Medical Center, Brainerd
at 11 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06395441

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Regions Hospital ( Site 0042), Saint Louis Park

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT06136559

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Mayo Clinic Rochester, Rochester

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Research Site, Rochester

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06542250

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Mayo Clinic Rochester, Rochester

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277231

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Mayo Clinic Rochester, Rochester

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06973187

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

University of Minnesota, Minneapolis

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03666000

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Mayo Clinic, Rochester

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

Allo HSCT Using RIC and PTCy for Hematological Diseases

Masonic Cancer Center at University of Minnesota, Minneapolis

Nagre-recruitPhase 2

Hanggang edad 75 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT05805605

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Masonic Cancer Center at University of Minnesota, Minneapolis

Nagre-recruitPhase 2

Hanggang edad 60 · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT03314974

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

Mayo Clinic, Rochester

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT07271667

CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

Mayo Clinic in Rochester, Rochester

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT04892277

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

Mayo Clinic in Rochester, Rochester

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT05876923

Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects

Mayo Clinic in Rochester, Rochester

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 40 pataas · Lahat ng kasarian · Na-update Mar 31, 2026 · NCT06536452

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Mayo Clinic- Minnesota, Rochester

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Mayo Clinic- Minnesota, Rochester

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876662

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Mayo Clinic in Rochester, Rochester

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT06151730

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

St. Lukes Hospital of Duluth /ID# 250021, Duluth

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT04895436

Q702 for the Treatment of Patients With Hematologic Malignancies

Mayo Clinic in Rochester, Rochester

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 10, 2025 · NCT06712810

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.